Williamson K. International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. PS-134.
Effectiviteit en veiligheid van verlengde profylaxe met letermovir
apr 2024 | Leukemie, Lymfoom, MDS, Stamceltransplantatie, Virale infecties